8095 Stock Overview
Manufactures and sells medicine-related products in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Astena Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥498.00 |
| 52 Week High | JP¥576.00 |
| 52 Week Low | JP¥417.00 |
| Beta | 0.040 |
| 11 Month Change | -6.04% |
| 3 Month Change | -0.60% |
| 1 Year Change | -0.20% |
| 33 Year Change | -11.86% |
| 5 Year Change | -0.80% |
| Change since IPO | -2.16% |
Recent News & Updates
Astena Holdings (TSE:8095) Has Affirmed Its Dividend Of ¥9.00
Oct 17
Astena Holdings Co., Ltd.'s (TSE:8095) Revenues Are Not Doing Enough For Some Investors
Aug 07Shareholder Returns
| 8095 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -2.5% | -7.3% | -1.8% |
| 1Y | -0.2% | 9.8% | 11.4% |
Return vs Industry: 8095 underperformed the JP Pharmaceuticals industry which returned 14.7% over the past year.
Return vs Market: 8095 underperformed the JP Market which returned 11.5% over the past year.
Price Volatility
| 8095 volatility | |
|---|---|
| 8095 Average Weekly Movement | 3.3% |
| Pharmaceuticals Industry Average Movement | 3.9% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.7% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 8095 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 8095's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1914 | 1,404 | Satoshi Setoguchi | www.astena-hd.com |
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company’s Fine Chemical division deals in the chemistry, manufacturing and control (CMC)/contract development and manufacturing organization (CDMO) and procurement platform businesses; and offers services for pharmaceutical development and manufacturing, from raw ingredient procurement to CMC research and development and commercial API production for antipyretic, analgesic and anti-inflammatory, and vasoconstrictor areas. The company’s Health & Beauty Care, and Food division delivers OTC drugs, functional food and cosmetic ingredients, and conducts mail-order sales of cosmetics and OEM products, including 1,3-butylene glycol, sodium acetylated hyaluronate, yeast extract, tomato powder, natural plant extract, natural plant extract, dehydrate potato, and meat extract powder.
Astena Holdings Co., Ltd. Fundamentals Summary
| 8095 fundamental statistics | |
|---|---|
| Market cap | JP¥20.05b |
| Earnings (TTM) | JP¥2.09b |
| Revenue (TTM) | JP¥53.39b |
9.6x
P/E Ratio0.4x
P/S RatioIs 8095 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8095 income statement (TTM) | |
|---|---|
| Revenue | JP¥53.39b |
| Cost of Revenue | JP¥35.18b |
| Gross Profit | JP¥18.21b |
| Other Expenses | JP¥16.12b |
| Earnings | JP¥2.09b |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 51.94 |
| Gross Margin | 34.11% |
| Net Profit Margin | 3.92% |
| Debt/Equity Ratio | 53.7% |
How did 8095 perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield51%
Payout RatioDoes 8095 pay a reliable dividends?
See 8095 dividend history and benchmarks| Astena Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Nov 28 2024 |
| Dividend Pay Date | Feb 28 2025 |
| Days until Ex dividend | 9 days |
| Days until Dividend pay date | 101 days |
Does 8095 pay a reliable dividends?
See 8095 dividend history and benchmarks